MarketInOut Stock Screener Log In | Sign Up

ABVC BioPharma Inc

NASDAQ • Healthcare • Biotechnology • Quote as of 11/06/2026
ABVC BioPharma Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization25.63 mln
Float21.87 mln
Earnings Date11/03/2026

Piotroski F-Score

1 / 9
Very weak

Relative Strength

32 / 100
Underperforming

Debt / Equity

0.28
Very low leverage

Pre-Tax Margin

1,055%
Exceptional margin

ROE

-69.34
Deeply negative

ROA

-36.39
Deeply negative

Business Description

ABVC BioPharma is a California-based company working to bring new treatments to patients with serious conditions that currently have few good options. The company has a broad pipeline of drugs and medical devices moving through clinical trials, targeting areas such as breast cancer, depression, ADHD, lung cancer, pancreatic cancer, and eye conditions. ABVC advances its work through partnerships with several life sciences organizations, combining shared resources and expertise to move its products closer to market.

Key Fundamentals

EPS-0.30
ROE-69.34
ROIC-29.76
ROA-36.39
Interest Cover-47.11
EBITDA, mln-6.95
EV / EBITDA-4.56
EV / EBIT-4.26

Quote Details

Last 0.9688
Change -0.0024 (-0.25%)
Open 0.96
Volume 20,527
Turnover 19,887
Average Volume 42,211

Financial Ratios

Pre-Tax Profit Margin1,055
Leverage Ratio1.89
Current Ratio0.07
Price / Book2.48
Price / Tangible Book2.48
Debt / Equity0.28

Financial Strength

Piotroski F-Score 1 / 9
Short Ratio4.96
Short % of Float2.70

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -3.12% 36 / 100   
1 Month -1.14% 57 / 100   
2 Months -6.85% 47 / 100   
6 Months -8.6% 50 / 100   
1 Year -66.48% 11 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog